Strong Diabetes Franchise Growth Highlights Solid Third Quarter For Merck
Three new product launches also were among the bright spots in a quarter in which the pharma posted net income of $342 million.
Three new product launches also were among the bright spots in a quarter in which the pharma posted net income of $342 million.